Literature DB >> 26956797

Studies on novel HIF activators, A-503451sII: biological activities of A-503451A.

Hideki Kobayashi1, Takao Ohyama2, Michiko Kitamura-Miyazaki3, Yuki Hirota-Takahata4, Osamu Ando5.   

Abstract

In the course of our screening, we discovered a novel compound, A-503451A, as a potent hypoxia-inducible factor (HIF) activator. In human hepatocarcinoma HepG2 cells, A-503451A induced HIF-mediated luciferase reporter gene expression and stabilized HIF-1α protein. A-503451A increased the mRNA expression levels and the protein secretion of HIF-dependent genes, vascular endothelial growth factor and erythropoietin. Addition of excess ferric chloride to the culture medium suppressed the HIF-induction activity of A-503451A. A-503451A did not have iron-chelating activity in vitro, but decreased the intracellular labile iron pool concentration. These data indicate that A-503451A is a unique HIF activator.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26956797     DOI: 10.1038/ja.2016.20

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  26 in total

1.  Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells.

Authors:  Hava Glickstein; Rinat Ben El; Maya Shvartsman; Z Ioav Cabantchik
Journal:  Blood       Date:  2005-07-14       Impact factor: 22.113

2.  Studies on novel HIF activators, A-503451s.I. Producing organism, fermentation, isolation and structural elucidation.

Authors:  Yuki Hirota-Takahata; Hideki Kobayashi; Masaaki Kizuka; Takao Ohyama; Michiko Kitamura-Miyazaki; Yasuhiro Suzuki; Mie Fujiwara; Mutsuo Nakajima; Osamu Ando
Journal:  J Antibiot (Tokyo)       Date:  2016-03-09       Impact factor: 2.649

3.  Gallate, the component of HIF-inducing catechins, inhibits HIF prolyl hydroxylase.

Authors:  Fuyo Tsukiyama; Yumi Nakai; Masataka Yoshida; Takahiro Tokuhara; Kiichi Hirota; Akiko Sakai; Hideyuki Hayashi; Takahiro Katsumata
Journal:  Biochem Biophys Res Commun       Date:  2006-10-23       Impact factor: 3.575

4.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

5.  A conserved family of prolyl-4-hydroxylases that modify HIF.

Authors:  R K Bruick; S L McKnight
Journal:  Science       Date:  2001-10-11       Impact factor: 47.728

6.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

7.  Hinokitiol activates the hypoxia-inducible factor (HIF) pathway through inhibition of HIF hydroxylases.

Authors:  Myong Jin Lee; Jeong Won Kim; Eun Gyeong Yang
Journal:  Biochem Biophys Res Commun       Date:  2010-04-21       Impact factor: 3.575

Review 8.  Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions.

Authors:  Ji-Won Lee; Seong-Hui Bae; Joo-Won Jeong; Se-Hee Kim; Kyu-Won Kim
Journal:  Exp Mol Med       Date:  2004-02-29       Impact factor: 8.718

9.  Tumor necrosis factor-alpha causes accumulation of a ubiquitinated form of hypoxia inducible factor-1alpha through a nuclear factor-kappaB-dependent pathway.

Authors:  Jie Zhou; Tobias Schmid; Bernhard Brüne
Journal:  Mol Biol Cell       Date:  2003-02-06       Impact factor: 4.138

10.  Effect of protein kinase and phosphatase inhibitors on expression of hypoxia-inducible factor 1.

Authors:  G L Wang; B H Jiang; G L Semenza
Journal:  Biochem Biophys Res Commun       Date:  1995-11-13       Impact factor: 3.575

View more
  1 in total

Review 1.  Bacterial terpenome.

Authors:  Jeffrey D Rudolf; Tyler A Alsup; Baofu Xu; Zining Li
Journal:  Nat Prod Rep       Date:  2021-05-26       Impact factor: 15.111

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.